Advertisement
Canada markets open in 5 hours 7 minutes
  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CAD/USD

    0.7313
    -0.0007 (-0.10%)
     
  • CRUDE OIL

    83.37
    +0.01 (+0.01%)
     
  • Bitcoin CAD

    91,176.52
    +771.85 (+0.85%)
     
  • CMC Crypto 200

    1,436.68
    +12.58 (+0.88%)
     
  • GOLD FUTURES

    2,331.20
    -10.90 (-0.47%)
     
  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     
  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     
  • NASDAQ futures

    17,720.25
    +113.50 (+0.64%)
     
  • VOLATILITY

    15.76
    +0.07 (+0.45%)
     
  • FTSE

    8,083.57
    +38.76 (+0.48%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6837
    +0.0001 (+0.01%)
     

Will These Management Changes Drive Dentsply Sirona toward a New Growth Trajectory?

Will These Management Changes Drive Dentsply Sirona toward a New Growth Trajectory?

Starting in October 2017, Dentsply Sirona (XRAY) implemented a series of management changes with the aim of positioning the company as a stronger and more efficient organization and maintaining the company’s leadership position in dentistry. In October, the company accepted the resignations of Executive Chairman Bret W. Wise, CEO and Director Jeffrey T. Slovin, and President and COO (chief operating officer) Christopher T. Clark. Mark A. Thierer was appointed interim CEO, and Bob Size was appointed interim president and COO. Mark A. Thierer has around 30 years of healthcare industry experience and most recently served as the CEO of OptumRx.